Getting tested for endometriosis typically involves a combination of clinical evaluation, imaging, and sometimes surgery. The process takes longer than most people expect: from first symptoms to a formal diagnosis, the total time ranges from 5 to 12 years depending on where you live. In the United States, that window is closer to 5 to 8 years. Part of the delay comes from patients waiting 1 to 4 years before seeking medical attention, but a significant portion is clinical delay, meaning the time doctors spend working through possible explanations. Understanding the diagnostic steps can help you navigate this process faster.
The Pelvic Exam: What Doctors Check First
A pelvic exam is usually the starting point. Your doctor uses one or two gloved fingers to feel for physical changes in the pelvis: cysts on the ovaries, painful spots, irregular growths called nodules, and scarring behind the uterus. A fixed or immobile uterus can also signal that adhesions from endometriosis are tethering organs together.
The limitation is real, though. Small areas of endometriosis often can’t be felt at all unless a cyst has already formed. A normal pelvic exam does not rule out endometriosis. It’s a first step, not a final answer.
Transvaginal Ultrasound
Transvaginal ultrasound (TVUS) is the most accessible imaging tool for endometriosis and the one most doctors turn to first. A small probe is inserted into the vagina to produce detailed images of the pelvic organs. For ovarian endometriomas (the fluid-filled cysts sometimes called “chocolate cysts”), TVUS is highly reliable, detecting them with about 95% sensitivity and 99% specificity. That means it catches nearly all endometriomas and almost never flags something as an endometrioma when it isn’t one.
For deep endometriosis, the kind that infiltrates more than 5 millimeters below the surface of the pelvic lining, TVUS sensitivity ranges from 84% to 100% depending on the specific location. Specificity stays above 97% across sites. The catch is that superficial endometriosis, the small implants scattered across the peritoneal surface, generally doesn’t show up on ultrasound at all. So a clean ultrasound doesn’t mean you’re free of the disease.
Pelvic MRI for Deeper Mapping
When ultrasound findings are inconclusive or when a doctor suspects deep infiltrating endometriosis, MRI provides a more detailed map. MRI picks up signals that correspond to specific tissue changes: cystic areas from enlarged glands, hemorrhagic (bleeding) deposits within lesions, and fibrotic scarring where tissue has hardened over time.
MRI is particularly useful for spotting endometriosis in harder-to-reach places. It can identify nodules pressing on the ureters, thickening along the uterine ligaments, lesions infiltrating the bowel wall, and involvement of the pelvic floor muscles. It also reveals indirect signs of adhesions, such as organs pulled out of their normal position, fluid trapped in pockets, or the disappearance of the normal fat layer between pelvic structures. Agreement between abbreviated and full MRI protocols is consistently above 93% across all pelvic sites, which means even shorter scan protocols capture the relevant findings.
MRI doesn’t replace ultrasound. It supplements it when the clinical picture suggests more extensive disease or when surgical planning requires a detailed roadmap.
Blood Tests: What CA-125 Can and Can’t Tell You
CA-125 is a protein that can be measured with a simple blood draw. Levels at or above 30 units per milliliter are associated with endometriosis, but the test has a significant blind spot. Its specificity is 96%, meaning a high result is strongly predictive of endometriosis, with a post-test probability of 94% in women who already have pelvic pain or difficulty conceiving. However, its sensitivity is only 57%. That means it misses nearly half of all cases. A normal CA-125 level cannot rule out endometriosis.
Because of this lopsided performance, CA-125 works best as a “rule-in” test. If the number comes back elevated in someone with the right symptoms, it strengthens the case for endometriosis. If it comes back normal, it tells you very little.
Endometrial Biopsy for Inflammation Markers
A newer approach involves testing a small sample of the uterine lining for a specific protein called BCL-6 that signals chronic inflammation linked to endometriosis. This test, available commercially as ReceptivaDx, has a published sensitivity of 93% and specificity of 96% for detecting endometriosis. It’s primarily used in fertility settings, where identifying hidden endometriosis can change the treatment strategy before proceeding with IVF. The biopsy itself is an office procedure, not surgery, making it far less invasive than laparoscopy.
Laparoscopy: The Surgical Diagnosis
Laparoscopy has long been the definitive way to confirm endometriosis. It’s a surgery performed under general anesthesia. Your surgeon makes a small incision near the bellybutton (sometimes more than one), inflates the abdomen with gas for visibility, and inserts a thin camera called a laparoscope. This allows direct visualization of endometriotic lesions on the pelvic surfaces, ovaries, and organs.
When suspicious tissue is found, the surgeon can remove it during the same procedure and send it for biopsy. Histological confirmation, meaning a pathologist examines the tissue under a microscope, is the gold standard for diagnosis. In many cases, the diagnostic surgery doubles as the first treatment, since lesions are excised or destroyed at the time of discovery.
The trend in recent years has been to rely less on surgery for initial diagnosis and more on a combination of imaging, symptoms, and biomarkers. Laparoscopy still plays a central role, but it’s increasingly reserved for cases where treatment is planned at the same time or when non-invasive methods haven’t provided a clear answer.
Conditions That Mimic Endometriosis
Part of the reason diagnosis takes so long is that endometriosis symptoms overlap with many other conditions. Pelvic pain and period-related discomfort also show up in adenomyosis (where endometrial-like tissue grows into the muscular wall of the uterus), uterine fibroids, pelvic inflammatory disease, and cervical stenosis. Gastrointestinal symptoms like bloating, pain with bowel movements, and irregular stool patterns can look identical to irritable bowel syndrome or inflammatory bowel disease. Bladder pain and urinary frequency overlap with interstitial cystitis. Your doctor may need to systematically exclude these conditions before landing on an endometriosis diagnosis, which adds time but also ensures the right treatment.
Staging After Diagnosis
Once endometriosis is confirmed, it’s classified using a point-based staging system. Stage I (minimal) scores 1 to 5 points, Stage II (mild) scores 6 to 15, Stage III (moderate) scores 16 to 40, and Stage IV (severe) scores above 40. Points are assigned based on the size, depth, and location of lesions plus the extent of adhesions. A single finding of complete obliteration of the cul-de-sac, the space behind the uterus, scores 40 points on its own and automatically places you in Stage IV. Deep ovarian endometriosis larger than 3 centimeters scores 20 points.
One thing that surprises many people: the stage doesn’t reliably predict pain levels. Someone with Stage I can have debilitating symptoms, while someone with Stage IV may have relatively mild pain. The staging system describes the physical extent of disease, not how it feels.
Salivary Testing on the Horizon
A saliva-based test called Endotest, developed by the company Ziwig, analyzes a panel of 109 small RNA molecules to identify an endometriosis-specific signature. In initial studies, it reached 96.7% sensitivity and 100% specificity. An interim analysis of 200 participants in a larger validation study showed similar results: 96.2% sensitivity and 95.1% specificity. The test became commercially available in France in 2022, though adoption remains limited. In a survey of German gynecologists, only about 15% reported having used it. If these accuracy numbers hold up in broader populations, saliva testing could eventually shorten the years-long diagnostic journey significantly.